Gibbons CH. Basics of autonomic nervous system function. Handb Clin Neurol. 2019;160:407–18.
Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63–79.
• Kaur D, Tiwana H, Stino A, Sandroni P. Autonomic neuropathies. Muscle Nerve. 2021;63(1):10–21. This is an excellent review which categorizes peripheral autonomic neuropathies based on their acute/subacute or chronic onset.
• Lamotte G, Sandroni P. A practical approach to peripheral autonomic neuropathies. Curr Opin Neurol. 2021;34(5):638–47. This review focuses on the practical approach of individuals with peripheral autonomic neuropathies with an emphasis on the autonomic history and physical examination.
Goldstein DS, Cheshire WP Jr. The autonomic medical history. Clin Auton Res. 2017;27(4):223–33.
PubMed PubMed Central Google Scholar
•• Cheshire WP, Freeman R, Gibbons CH, et al. Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021;132(2):666–82. This is the most recent consensus statement on autonomic testing.
Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol. 1983;14:573–80.
Low PA. Autonomic nervous system function. J Clin Neurophysiol. 1993;10(1):14–27.
Pickering TG, Sleight P. Quantitative index of baroreflex activity in normal and hypertensive subjects using Valsalva’s manoeuvre. Br Heart J. 1969;31(3):392.
Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology. 2005;65:1533–7.
•• Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83(3):522–31. This important study validated the ratio of orthostatic heart rate changes over systolic blood pressure changes to identify individuals with neurogenic orthostatic hypotension.
PubMed PubMed Central Google Scholar
Balagny P, Wanono R, d’Ortho MP, Vidal-Petiot E. Reply to validation of the new diagnostic tests for neurogenic orthostatic hypotension. Ann Neurol. 2018;84(6):957–8.
Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64(6):617–28.
•• Koay S, Vichayanrat E, Bremner F, et al. Multimodal biomarkers quantify recovery in autoimmune autonomic ganglionopathy. Ann Neurol. 2021;89(4):753–68. This study demonstrated the role of quantitative autonomic function testing to monitor the response to treatment in individuals with autoimmune autonomic ganglionopathy.
Robertson D, Hollister AS, Biaggioni I. Arterial baroreflex failure in man. Clin Auton Res. 1993;3:212.
Potockova V, Mala S, Hoskovcova L, et al. Thermal quantitative sensory testing as a screening tool for cardiac autonomic neuropathy in patients with diabetes mellitus. Brain Behav. 2022;12(3): e2506.
CAS PubMed PubMed Central Google Scholar
•• Lamotte G, Coon EA, Suarez MD, et al. Standardized autonomic testing in patients with probable radiation-induced afferent baroreflex failure. Hypertension. 2022;79(1):50–6. This study described the pattern of autonomic dysfunction on standardized autonomic testing in patients with probable radiation-induced afferent baroreflex failure.
Shouman K, Sandroni P. Antibody testing for suspected autoimmune autonomic dysfunction and small fiber neuropathies. J Clin Neurophysiol. 2021;38(4):274–8.
Cutsforth-Gregory JK, McKeon A, Coon EA, et al. Ganglionic antibody level as a predictor of severity of autonomic failure. Mayo Clin Proc. 2018;93(10):1440–7.
• Karagiorgou K, Dandoulaki M, Mantegazza R, et al. Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1162. https://doi.org/10.1212/NXI.0000000000001162. Print 2022 May.
Gibbons CH. A double-blind, placebo controlled trial of Gamunex-C in patient with small fiber neuropathy associated with autoantibodies to TS-HDS and FGFR3 (P8-13.002). Neurology. 2022;98(18 Supplement).
Gertz MA, Mauermann ML, Grogan M, Coelho T. Advances in the treatment of hereditary transthyretin amyloidosis: a review. Brain Behav. 2019;9(9): e01371.
PubMed PubMed Central Google Scholar
• Adams D, Ando Y, Beirão JM, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268(6):2109–22. This review outlines detailed recommendations to improve the diagnosis of ATTR amyloidosis with peripheral neuropathy.
•• Carroll A, Dyck PJ, de Carvalho M, et al. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol, Neurosurg Psychiatr 2022. This review highlights the key advances in the diagnostic techniques, current and emerging management strategies, and biomarker development for disease progression in hereditary transthyretin amyloidosis.
Adams D, Suhr OB, Hund E, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Current opinion in neurology. 2016;29(Suppl 1):S14–26.
CAS PubMed PubMed Central Google Scholar
Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–12.
Klein CJ, Vrana JA, Theis JD, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol. 2011;68(2):195–9.
Rezk T, Gilbertson JA, Mangione PP, et al. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis. J Pathol Clin Res. 2019;5(3):145–53.
CAS PubMed PubMed Central Google Scholar
Wu TY, Taylor JM, Kilfoyle DH, et al. Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia “CANVAS” syndrome. Brain. 2014;137(Pt 10):2649–56.
Beijer D, Dohrn MF, De Winter J, et al. RFC1 repeat expansions: a recurrent cause of sensory and autonomic neuropathy with cough and ataxia. Eur J Neurol. 2022;29(7):2156–61.
Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep. 2011;15(3):193–200.
PubMed PubMed Central Google Scholar
Provitera V, Gibbons CH, Wendelschafer-Crabb G, et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol. 2016;23(2):333–8.
Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. 2004;127(Pt 7):1593–605.
Baskozos G, Sandy-Hindmarch O, Clark AJ, et al. Molecular and cellular correlates of human nerve regeneration: ADCYAP1/PACAP enhance nerve outgrowth. Brain. 2020;143(7):2009–26.
PubMed PubMed Central Google Scholar
Bennett DL, Woods CG. Painful and painless channelopathies. The Lancet Neurology. 2014;13(6):587–99.
Wu B, Pak DM, Smith KD, Shinohara MM. Utility of abdominal skin punch biopsy for detecting systemic amyloidosis. J Cutan Pathol. 2021;48(11):1342–6.
Wang N, Gibbons CH, Lafo J, Freeman R. alpha-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81(18):1604–10.
CAS PubMed PubMed Central Google Scholar
• Levine TD, Bellaire B, Gibbons C, Freeman R. Cutaneous alpha-synuclein deposition in postural tachycardia patients. Ann Clin Transl Neurol. 2021;8(4):908–17. In this study, a subgroup of patients with postural tachycardia had evidence of cutaneous alpha-synuclein deposition.
CAS PubMed PubMed Central Google Scholar
• Miglis MG, Seliger J, Shaik R, Gibbons CH. A case series of cutaneous phosphorylated α-synuclein in Long-COVID POTS. Clin Auton Res: Off J Clin Auton Res Soc. 2022;32(3):209–12. In this research letter, the authors report phosphorylated alpha-synuclein in skin biopsy samples in five young patients with long-COVID postural tachycardia syndrome.
Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest vesrion. Circ J. 2012;76(2):508–19.
Lodhi HA, Peri-Okonny PA, Schesing K, et al. Usefulness of blood pressure variability indices derived from 24-hour ambulatory blood pressure monitoring in detecting autonomic failure. J Am Heart Assoc. 2019;8(7): e010161.
PubMed PubMed Central Google Scholar
•• Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267–9. This is an excellent review of the neurological complications of COVID-19.
Goldstein DS. Principles of Autonomic Medicine. https://neuroscience.nih.gov/publications/Principles%20of%20Autonomic%20Medicine%20v.%202.1.pdf2020. Accessed 1 Nov 2022.
Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res: Off J Clin Auton Res Soc. 2020;30(4):299–315.
Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. 2020;21:100276.
PubMed PubMed Central Google Scholar
Lamotte G, Benarroch EE, Coon EA. Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID-19 Infection. Clin Auton Res: Off J Clin Auton Res Soc. 2021;31(2):327–9.
Mostel Z, Ayat P, Capric V, Trimmingham A, McFarlane SI. Guillain-Barré syndrome in a COVID-19 patient: a case report and review of management strategies. Am J Med Case Rep. 2021;9(3):198–200.
PubMed PubMed Central Google Scholar
•• Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clinical autonomic research: official journal of the Clinical Autonomic Research Society. 2021;31(3):385–94. This case series demonstrated that abnormalities on autonomic testing were seen in the majority of patients with persistent symptoms following COVID-19 infection but were mild in most cases. The most common finding was orthostatic intolerance, often without objective hemodynamic abnormalities on testing.
Stute NL, Stickford JL, Province VM, Augenreich MA, Ratchford SM, Stickford ASL. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. J Physiol. 2021;599(18):4269–85.
Banerjee D, Roeker LE, Grogan M, et al. Outcomes of patients with familial transthyretin amyloidosis after liver transplantation. Prog Transplant. 2017;27(3):246–50.
Bulawa CE, Connelly S, Devit M, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A. 2012;109(24):9629–34.
留言 (0)